We're doing this study to explore how a device called TheraBionic affects people with liver cancer and their condition. This device uses special frequencies to target cancer cells and is being tested for treating advanced liver cancer.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Andrew Moon
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Liver)
Kidneys and Liver
25-2366
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
